Table 2 Demographic and disease cCharacteristics for PsO patients
From: Differences in oxylipin profile in psoriasis versus psoriatic arthritis
Variable | Psoriasis group N = 20 |
|---|---|
Age (years) (mean, SD) | 51.9 (± 10.8) |
Sex F:M | 9:11 (55% male) |
BMI (kg/m2) (mean, SD) | 33.7 (± 6.8) |
PASI (mean, SD) | 3.8 (± 4.2) |
BSA (mean, SD) | 4.5 (± 4.7) |
TJC | 3.05 (4.8) |
Enthesitis (%) | 25% |
Enthesitis (LEI mean) | 1.5 (2.79) |
NSAIDs (%) | 35% |
DMARDs | 10% |
TNF alpha inhibitors (%) | 0 |
Corticosteroids (%) | 0 |
Topical corticosteroids (%) | 75% |